19 earn accreditation in 2015, reflecting steady progress
WASHINGTON, D.C.âThe Association for the Accreditation of Human Research Protection Programs today announced that it has accredited three more research organizations, including two health systems and one academic medical center.
All told, 19 organizations earned AAHRPP accreditation in 2015, including the first historically black college and the first organizations in Europe. AAHRPP continued to make strong inroads across the U.S. and in Asia.
The newly accredited organizations are:
ï· Lancaster General Health, Lancaster, Pennsylvania
ï· Main Line Health, Bryn Mawr, Pennsylvania
ï· University of Massachusetts Worcester, Worcester, Massachusetts
“We are determined to bring the benefits of AAHRPP accreditation to research participants here at home and around the globe,” AAHRPP President and CEO Elyse I. Summers said. “With each accreditation, we take an important step toward realizing the goal of one standard worldwide for research protections.
“We congratulate and applaud all 219 AAHRPP-accredited organizations for their commitment to AAHRPP’s high standards and to high-quality, ethical research.”
AAHRPP-accredited organizations include universities, academic medical centers, community and specialty hospitals, independent institutional review boards, contract research organizations, dedicated research sites, research sponsors, and public health departments.
To earn AAHRPP accreditation, organizations must demonstrate that they have built extensive safeguards into every level of their research operation and that they adhere to high standards for research. In today’s global, collaborative research enterprise, organizations increasingly rely on AAHRPP accreditation status to help identify trusted research partners.
To date, AAHRPP has accredited organizations in 46 states, Belgium, Canada, China, India, Mexico, Republic of Korea, Saudi Arabia, Singapore, Taiwan, and Thailand. All major U.S. independent institutional review boards have earned AAHRPP accreditation. In addition, more 2 than 60 percent of U.S. research-intensive universities and over 65 percent of U.S. medical schools are either AAHRPP accredited or have begun the accreditation process. The National Institutes of Health, the world’s largest public funder of research, has earned accreditation, as has Pfizer, Inc., the largest industry sponsor of clinical research.
About AAHRPP: A nonprofit organization, AAHRPP provides accreditation for organizations that conduct or review human research and can demonstrate that their protections exceed the safeguards required by the U.S. government. To learn more, visit www.aahrpp.org.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.